The glutathione peptide is a chain of just three amino acids that the body makes for itself, and it is one of the most studied molecules in antioxidant research. It is often grouped with peptides, yet it behaves differently from most of them, and it is hard to keep stable in a vial. This guide explains in plain words what glutathione is, how it works, what studies found on skin and aging, which benefits have been tested, what amounts trials used, and what the research shows. It describes research only and is not advice for any person.
What Is Glutathione?
Glutathione, shortened to GSH, is a tripeptide, which means a chain of three amino acids, the building blocks of proteins. According to Wikipedia, the three are glutamate, cysteine, and glycine. Wikipedia calls it the most abundant non-protein thiol in the cells of the body. A thiol is a chemical group made of sulfur and hydrogen, the “SH” in GSH, which can hand off electrons.
Cells make it themselves in two steps. A 2004 review in the Journal of Nutrition says production is controlled mainly by one enzyme and by how much cysteine is available. Levels inside cells run from 0.5 to 10 mmol/L, which can be up to 1,000 times higher than in the fluid outside cells, according to Wikipedia.
It comes in two forms. Reduced glutathione (GSH) is the working form. Oxidized glutathione (GSSG) is two molecules joined by a sulfur bridge. In healthy cells, more than 90 percent is in the reduced form. The table lists the forms and the related compounds people often mix up with it.
| Form | What it is | Why researchers care |
|---|---|---|
| GSH (reduced glutathione) | The working form, with a free sulfur-hydrogen group | The form cells use and keep in large amounts |
| GSSG (oxidized glutathione) | Two GSH molecules joined by a sulfur bridge | A rising share of GSSG is a sign of more oxidative stress, and it is the form reported to be more stable in solution |
| NAC | A cysteine donor | Studied as a way to support the body’s own glutathione production |
| GlyNAC | Glycine plus NAC | Tested in older adults as a way to restore glutathione levels |
Glutathione also works differently from many research peptides. Several compounds in the longevity compounds guide act mainly as signals. Glutathione acts more like a chemical helper that keeps cells in balance.
How Glutathione Works
The key idea is oxidative stress. This is an imbalance between reactive molecules that can damage fats, proteins, and DNA and the defenses that keep them in check. According to Wikipedia, the ratio of GSSG to GSH inside cells is used as a measure of it, and a higher share of GSSG points to more oxidative stress.
A 2023 review in Ageing Research Reviews explains that glutathione has some direct effects, but much of its antioxidant work is done through enzymes called glutathione peroxidases, which use it to remove hydrogen peroxide and similar damaging molecules. Wikipedia describes it as an indirect antioxidant, a partner to these enzymes, and says it also helps keep vitamins C and E in their active forms.
Three more points help in plain terms:
- It gets recycled. Inside cells, an enzyme called glutathione reductase turns used-up GSSG back into GSH using a helper molecule called NADPH, according to Wikipedia. A vial has no such system, so once glutathione is oxidized there, it stays that way.
- It helps clear toxic by-products. A 2009 overview in Molecular Aspects of Medicine says it protects cells from toxic substances as well as oxidative damage. Wikipedia notes it is used up when the body handles some drugs, such as acetaminophen.
- It breaks down in solution. A 2016 study in the journal Chemistry found oxygen alone does not oxidize it without a catalyst, but trace copper speeds up the change to GSSG. A 2022 study in the Journal of Parenteral and Enteral Nutrition found about 30 percent of GSSG was lost in nutrition solutions, mainly through a reaction with cysteine.
See also: What Is SS-31 Peptide and What Current Research Shows
Glutathione and Skin Research
Skin is the most popular use of glutathione outside the lab, and the best place to see how thin the evidence is. A 2016 review in the Indian Journal of Dermatology, Venereology and Leprology says the proposed idea is that glutathione blocks tyrosinase, an enzyme that makes pigment, and shifts the body toward making lighter pigment.
Several small trials of oral glutathione tested this:
- 500 mg a day for 4 weeks. A 2012 trial in the Journal of Dermatological Treatment gave 60 healthy medical students glutathione or placebo. Skin pigment dropped at all six sites measured, but the difference from placebo was significant at only two, the face and a sun-exposed forearm. The authors said long-term safety had not been established.
- 250 mg a day for 12 weeks. A 2017 trial in Clinical, Cosmetic and Investigational Dermatology gave healthy women reduced glutathione, oxidized glutathione, or placebo. Both forms tended to lower pigment. The reduced form also lowered wrinkles at some sites, and elasticity tended to improve.
- A combination. A 2022 trial in the Journal of Cosmetic Dermatology split 124 women into four groups for 12 weeks. They took cystine with glutathione, glutathione alone, cystine alone, or placebo. The combination lightened skin and dark spots more than placebo or either one alone.
The reviews are more careful. A 2019 systematic review in the Journal of Cosmetic Dermatology found only four studies and called the evidence inconclusive, with a trend toward brightening in sun-exposed skin. A 2025 review in the International Journal of Dermatology found oral glutathione at 250 to 500 mg a day lowered pigment against placebo in five trials, but described the effects as unsustainable.
Injected glutathione is the biggest concern. The 2016 Indian review says injections are popular without any evidence they work, and that the Philippine drug regulator issued a public warning against their use for skin lightening. A 2016 review in the South African Medical Journal found no studies of injected glutathione for this purpose or of its safety with long-term use. It also raised a concern that the change in pigment type could raise sun-related skin cancer risk.
For anti-aging, the picture is the same. The wrinkle result above is small and from one trial. A 2026 review in Nutrients says glutathione levels typically decline with age, but a drop in levels does not prove that raising them slows aging.
See also: Peptides for Skin and What Current Research Examines
Glutathione Benefits in Current Research
People credit glutathione with many benefits. The list below sorts what has been studied by how well supported it is. Details follow in the research section.
- Cell protection. Well established as a role in the body. This describes what glutathione does naturally, not what a supplement does.
- Raising glutathione levels. Supported by two small trials, with a caveat. Blood levels rose, but those studies measured levels, not health results.
- Immune markers. Early signs only. Two small studies saw higher natural killer cell activity, a type of immune cell activity, but did not test whether people got sick less often.
- Skin tone. Small, short trials with modest, localized effects.
- Aging. Not shown. The data link low levels with older age, but trials tested glycine and NAC, not glutathione.
- Brain and nerve conditions. Not established. Trials in Parkinson’s disease gave mixed or no clear benefit.
- Lung conditions. Not shown in the one large trial, in cystic fibrosis.
See also: GHK-Cu Benefits, What Current Research Examines
Glutathione Dosage in Published Research
There is no standard dose, and the amounts below are not instructions. They are amounts used in clinical trials of glutathione products. Trial amounts apply to the specific product and route tested, so they do not carry over to research material.
- By mouth. A 2015 trial in the European Journal of Nutrition used 250 or 1,000 mg a day for 6 months. A 2018 pilot study used liposomal glutathione at 500 or 1,000 mg a day for 1 month. The skin trials above used 250 to 500 mg a day for 4 to 12 weeks.
- Injected into a vein. A 2009 trial in Movement Disorders used 1,400 mg three times a week for 4 weeks.
- Through the nose. A 2017 trial in the Journal of Parkinson’s Disease used 100 or 200 mg three times a day for 3 months.
- Inhaled. A 2013 trial in the American Journal of Respiratory and Critical Care Medicine used 646 mg every 12 hours for 6 months.
Why do the numbers vary so much? Delivery is a big reason. Wikipedia says the systemic availability of glutathione taken by mouth is poor, because digestive enzymes break it down and cells have no specific carrier for it. A 2015 review in Current Drug Metabolism and a 2024 review in Current Molecular Medicine both describe low bioavailability and poor stability as limits. Stability matters in the lab too. Because trace copper speeds oxidation and mixing with other ingredients can destroy part of it, a batch-specific Certificate of Analysis that states the form, along with clean containers and a record of when a solution was made, helps. The peptide reconstitution guide, the reconstitution ratios guide, and the bacteriostatic water guide cover general laboratory steps.
What Does the Research Show?
Overall, the human research is small, short, and mixed. The table sums up the main studies.
| Area | What was tested | What was found |
|---|---|---|
| Body levels | 54 adults took glutathione by mouth for 6 months | At the higher amount, levels rose 30 to 35 percent in red blood cells, plasma, and white blood cells, and returned to baseline after a one-month break |
| Body levels | 12 adults took liposomal glutathione for 1 month | Whole blood levels rose by up to 40 percent in a small pilot study |
| Skin | Oral glutathione in small trials | Modest, localized lightening, with reviews calling the evidence inconclusive |
| Older adults | 24 older adults took GlyNAC for 16 weeks | Lower glutathione and signs of oxidative stress improved, in a small trial of glycine and NAC |
| Parkinson’s disease | Injected, nasal, and pooled trials | Mixed, with some small motor-score gains and no clear edge over placebo in the nasal trial |
| Cystic fibrosis | 153 people inhaled glutathione for 6 months | No clinically relevant gain in lung function |
A few details matter. In the 2015 trial, glutathione’s oxidized-to-reduced ratio in blood also fell, which points to less oxidative stress. In the Parkinson’s disease work, a 2009 pilot with 21 people found no significant difference from placebo, a 2017 study of 45 people found neither nasal dose was better than placebo, and a 2021 pooled analysis of seven trials with 450 people found a mild motor-score improvement. A 2026 systematic review called the findings for glutathione itself inconclusive, while NAC looked more promising. In the cystic fibrosis trial, glutathione reached the lungs but did not change markers of oxidation or inflammation.
The takeaway is that glutathione is a real and important molecule, but adding more of it from outside the body has not been shown to produce the benefits people hope for. A 2026 review in Nutrients concludes that supplements built from its parts, such as glycine, show stronger and more consistent increases in human levels than glutathione itself.
Key Takeaways
- What it is. Glutathione is a tripeptide of glutamate, cysteine, and glycine that cells make for themselves.
- How it works. It acts mostly as a helper to enzymes that remove damaging molecules, and cells recycle it. A vial cannot.
- Skin. Small oral trials show modest, localized lightening. The injected form has little evidence and safety concerns.
- Aging. Levels fall with age, but no trial shows that glutathione itself slows aging.
- Benefits. Raising blood levels is supported. Health benefits are not established.
- Dosage. Trial amounts apply to the product and route tested and are not guidance for research material.
- Stability. It oxidizes easily, trace copper speeds this up, and mixing can destroy part of it.
Frequently Asked Questions
What is the glutathione peptide?
It is a tripeptide made of glutamate, cysteine, and glycine, and the most abundant non-protein thiol in the cells of the body, according to Wikipedia.
How does glutathione work?
Mostly by helping enzymes remove damaging molecules and by keeping cells in chemical balance. Cells also recycle it, using an enzyme and a helper molecule.
Does glutathione lighten skin?
Small trials of oral glutathione show modest lightening in some areas. Reviews call the evidence inconclusive, and injected use has little evidence and safety concerns.
Does glutathione taken by mouth raise levels in the body?
The evidence is mixed. Wikipedia describes poor availability by mouth, while two small trials found higher blood levels after supplements. Those trials measured levels, not health results.
Is glutathione the same as NAC?
No. NAC is a cysteine donor that cells can use to build glutathione. They are related but different compounds.
Why is glutathione hard to keep stable?
It readily oxidizes into GSSG, trace copper speeds this up, and it can react with other ingredients in a mixture. A vial has no system to turn it back.
Research Use Disclaimer
This content is provided for Research Use Only (RUO). The compounds discussed are not drugs, dietary supplements, foods, or cosmetics, and are not intended for human or animal consumption, diagnostic use, or therapeutic use of any kind. They have not been evaluated by the FDA for safety or efficacy in humans. Any research use must be conducted by qualified professionals in a controlled laboratory environment, in accordance with all applicable institutional, local, and federal regulations.
Sources
- Wikipedia contributors. Glutathione. Wikipedia, The Free Encyclopedia.
- Forman HJ, et al. Glutathione, overview of its protective roles, measurement, and biosynthesis. Mol Aspects Med. 2009.
- Wu G, et al. Glutathione metabolism and its implications for health. J Nutr. 2004.
- Lapenna D. Glutathione and glutathione-dependent enzymes, from biochemistry to gerontology and successful aging. Ageing Res Rev. 2023.
- Kumar P, et al. Supplementing glycine and N-acetylcysteine (GlyNAC) in older adults, a randomized clinical trial. J Gerontol A Biol Sci Med Sci. 2023.
- Bradauskienė V, et al. Glutathione in our diet and its role in the body, from disease prevention to anti-aging. Nutrients. 2026.
- Richie JP Jr, et al. Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. Eur J Nutr. 2015.
- Sinha R, et al. Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function. Eur J Clin Nutr. 2018.
- Homma T, et al. Application of glutathione as anti-oxidative and anti-aging drugs. Curr Drug Metab. 2015.
- Dehkordi HT, et al. Glutathione therapy in diseases, challenges and potential solutions for therapeutic advancement. Curr Mol Med. 2024.
- Ngamchuea K, et al. The copper(II)-catalyzed oxidation of glutathione. Chemistry. 2016.
- Raichani NE, et al. Stability of glutathione added as a supplement to parenteral nutrition. JPEN J Parenter Enteral Nutr. 2022.
- Sonthalia S, et al. Glutathione as a skin whitening agent, facts, myths, evidence and controversies. Indian J Dermatol Venereol Leprol. 2016.
- Davids LM, et al. Intravenous glutathione for skin lightening, inadequate safety data. S Afr Med J. 2016.
- Arjinpathana N, Asawanonda P. Glutathione as an oral whitening agent, a randomized, double-blind, placebo-controlled study. J Dermatolog Treat. 2012.
- Weschawalit S, et al. Glutathione and its antiaging and antimelanogenic effects. Clin Cosmet Investig Dermatol. 2017.
- Duperray J, et al. The effects of the oral supplementation of L-cystine associated with reduced L-glutathione on human skin pigmentation, a randomized, double-blinded, benchmark- and placebo-controlled clinical trial. J Cosmet Dermatol. 2022.
- Dilokthornsakul W, Dhippayom T. The clinical effect of glutathione on skin color and other related skin conditions, a systematic review. J Cosmet Dermatol. 2019.
- Sarkar R, Yadav V. Glutathione as a skin-lightening agent and in melasma, a systematic review. Int J Dermatol. 2025.
- Hauser RA, et al. Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson’s disease. Mov Disord. 2009.
- Mischley LK, et al. Phase IIb study of intranasal glutathione in Parkinson’s disease. J Parkinsons Dis. 2017.
- Wang HL, et al. Potential use of glutathione as a treatment for Parkinson’s disease. Exp Ther Med. 2021.
- Mohammed I, et al. The role of N-acetylcysteine and glutathione in the management of Parkinson’s disease, a systematic review of oxidative biomarkers and clinical outcomes. Amino Acids. 2026.
- Griese M, et al. Inhalation treatment with glutathione in patients with cystic fibrosis, a randomized clinical trial. Am J Respir Crit Care Med. 2013.
Explore the anti-aging research category for related longevity compounds, or view the NAD+ and SS-31 research material. For related reading, see the NAD+ guide and the SS-31 guide.
